Treatment with PX478, an inhibitor of HIF1α, and Mithramycin A, an inhibitor of Sp1, resulted in a reversal of the upregulation of SPNS2 mRNA and protein expression caused by iron deficiency, with Mithramycin A exhibiting a more pronounced effect. Here, SP1 is linked to nutritional disorder.